Form 8-K - Current report:
SEC Accession No. 0001854270-25-000008
Filing Date
2025-02-25
Accepted
2025-02-25 16:34:23
Documents
15
Period of Report
2025-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20250223.htm   iXBRL 8-K 36617
2 PRESS RELEASE a202502258kex991.htm EX-99.1 13133
6 senti_logoxpra.jpg GRAPHIC 3383
  Complete submission text file 0001854270-25-000008.txt   190388

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20250223.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20250223_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20250223_pre.xml EX-101.PRE 13045
18 EXTRACTED XBRL INSTANCE DOCUMENT snti-20250223_htm.xml XML 2926
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 25663972
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)